Health Justice for Immigrants, Revisited
This blog post applies the health justice lens to inequities in immigrant health and access to health care.
Health Care Finance
-
Read more: Health Justice for Immigrants, Revisited -
Read more: Health Justice as the Lodestar of Incremental Health Reform Health Justice as the Lodestar of Incremental Health Reform
Health justice as a lodestar holds focus on the broader endeavor of protecting and promoting human health through tempestuous politics.
-
Read more: Expanded Reimbursement Codes for Remote Therapeutic Monitoring: What This Means for Digital Health Expanded Reimbursement Codes for Remote Therapeutic Monitoring: What This Means for Digital Health
New reimbursement codes for virtual patient monitoring may soon be incorporated into Medicare’s fee schedule.
-
Read more: Reforming How Medicare Pays for Digital Health Reforming How Medicare Pays for Digital Health
Reforms to Medicare’s traditional coverage and reimbursement approaches that harness the digital revolution can help the program secure additional value.
-
Read more: To Set the Price Tag for Telehealth, First Understand Its Value To Set the Price Tag for Telehealth, First Understand Its Value
Policy and regulation will play a significant role in determining whether these health care modalities are here to stay.
-
Read more: Pandemic Diagnostics: Present and Future Implications of Self-Testing Reimbursement Pandemic Diagnostics: Present and Future Implications of Self-Testing Reimbursement
At-home COVID-19 testing illustrates how even the most well-financed efforts can miss opportunities to ensure equity and expand access.
-
Read more: America’s Underinsurance Crisis in the Age of COVID-19 America’s Underinsurance Crisis in the Age of COVID-19
The COVID-19 pandemic has shone a light on the underinsurance crisis that has long kept millions of Americans on the precipice of financial disaster.
-
Read more: FDA Approves Aducanumab for Alzheimer’s Disease: An Unethical Decision? FDA Approves Aducanumab for Alzheimer’s Disease: An Unethical Decision?
FDA’s approval of aducanumab may run against the bioethical principles of beneficence and non-maleficence.
-
Read more: Aducanumab: A Bitter Pill to Swallow Aducanumab: A Bitter Pill to Swallow
Patients are understandably desperate, but their needs are best served by following the science, rather than lowering the standards for drugs.
-
Read more: Congress Should Insulate the Indian Health Service from the Next Government Shutdown Congress Should Insulate the Indian Health Service from the Next Government Shutdown
The fiscal fragility of the Indian Health Service creates real problems for Native peoples.
